The role of configurational entropy in amorphous systems

Pharmaceutics

Volumn 2, Issue 2, 2010, Pages 224-244

  Graeser, Kirsten A ^a,b   Patterson, James E ^b   Zeitler, J Axel ^c   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amorphous; Configurational entropy; Molecular mobility; Solubility

Indexed keywords

CEFUROXIME AXETIL; FENOFIBRATE; GRISEOFULVIN; IBUPROFEN; INDOMETACIN; LACIDIPINE; NIFEDIPINE; PARACETAMOL; SIMVASTATIN; TOLBUTAMIDE; TROGLITAZONE;

ARTICLE; CALORIMETRY; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENTROPY; GLASS TRANSITION TEMPERATURE; MATHEMATICAL COMPUTING; PHYSICAL CHEMISTRY; PREDICTION; SOLUBILITY; TEMPERATURE DEPENDENCE; TEMPERATURE MEASUREMENT; TEMPERATURE SENSITIVITY; THERMAL ANALYSIS; THERMODYNAMICS; THERMOSTABILITY;

EID: 79952165879     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics2020224     Document Type: Article

References (44)

1. Hancock, B.C.; Zografi, G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 1997, 86, 1-12.
2. Kerc, J.; Srcic, S. Thermal analysis of glassy pharmaceuticals. Thermochim. Acta 1995, 248,81-95.
3. Graeser, K.A.; Strachan, C.J.; Patterson, J.E.; Gordon, K.C.; Rades, T. Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin. Cryst. Growth & Des. 2008,8,128-135.
4. Patterson, J.E.; James, M.B.; Forster, A.H.; Lancaster, R.W.; Butler, J.M.; Rades, T. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int. J. Pharm. 2007, 336, 22-34.
5. Hilden, L.R.; Morris, K.R. Physics of amorphous solids. J. Pharm. Sci. 2004, 93, 3-12.
6. Yu, L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Del. Rev. 2001, 48, 27-42.
7. Schmelzer, J. Crystal nucleation and growth in glass-forming melts: Experiment and theory. J. Non-Cryst. Sol. 2008, 354, 269-278.
8. Longley, W., Ed. The Collected Works of J. Willard Gibbs; Yale University Press: New Haven, CT, USA, 1948; Volume 1 (Thermodynamics).
9. Rodríguez-Hornedo, N.; Murphy, D. Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J. Pharm. Sci. 1999, 88, 651-60.
10. Bhugra, C.; Pikal, M.J. Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state. J. Pharm. Sci. 2008, 97, 1329-49.
11. Yoshioka, M.; Hancock, B.C.; Zografi, G. Crystallization of indomethacin from the amorphous state below and above its glass-transition temperature. J. Pharm. Sci. 1994, 83, 1700-1705.
12. Hodge, I.M. Strong and fragile liquids-a brief critique. J. Non-Cryst. Sol. 1996, 202, 164-172.
13. Privalko, V.P. Excess entropies and related quantities in glass-forming liquids. J. Phys. Chem. 1980,84,3307-3312.
14. Hancock, B.C.; Shamblin, S.L. Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry. Thermochim. Acta 2001, 380, 12.
15. Shamblin, S.L.; Tang, X.; Chang, L.; Hancock, B.C.; Pikal, M.J. Characterization of the time scales of molecular motion in pharmaceutically important glasses. J. Phys. Chemi. B 1999, 103,4113-4121.
16. Tombari, E.; Ferrari, C.; Johari, G.P.; Shanker, R.M. Calorimetric relaxation in pharmaceutical molecular glasses and its utility in understanding their stability against crystallization. J. Phys. Chem. B 2008, 112, 10806-10814.
17. Yoshioka, S.; Aso, Y. Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals. J. Pharm. Sci. 2007, 96, 960-981.
18. Williams, G.; Watts, D.C. Non-symmetrical dielectric relaxation behaviour arising from a simple empirical decay function. Trans. Faraday Soc. 1970, 66, 80.
19. Adam, G.; Gibbs, J.H. On the temperature dependence of cooperative relaxation properties in glass-forming liquids. J. Chem. Phys. 1965, 43, 139.
20. Fulcher, G.S. Analysis of recent measurements of the viscosity of glasses. J. Am. Ceram. Soc. 1925,8,339-355.
21. Tammann, G.; Hesse, W. The dependency of viscosity on temperature in hypothermic liquids. Z. Anorg. Allg. Chem. 1926, 4, 156.
22. Vogel, H. The temperature dependence law of the viscosity of fluids. Physikal. Zeitschr. 1921, 22,645-646.
23. Johari, G.P. On extrapolating a supercooled liquid's excess entropy, the vibrational component, and reinterpreting the configurational entropy theory. J. Phys. Chem. B 2001, 105, 3600-3604.
24. Kawakami, K.; Pikal, M.J. Calorimetric investigation of the structural relaxation of amorphous materials: evaluating validity of the methodologies. J. Pharm. Sci. 2005, 94, 948-965.
25. Chiou, W.L.; Riegelman, S. Oral absorption of griseofulvin in dogs: Increased absorption via solid dispersion in polyethylene glycol 6000. J. Pharm. Sci. 1970, 59, 937-942.
26. Parks, G.S.; Snyder, L.J.; Cattoir, F.R. Studies on glass. XI. Some thermodynamic relations of glassy and alpha-crystalline glucose. J. Chem. Phys. 1934, 2, 595.
27. Parks, G.S.; Huffman, S.W.; Cattoir, F.R. Studies on glass. II. The transition between the glassy and liquid states in the case of glucose. J. Phys. Chem. 1928, 32, 1366-1379.
28. Aguiar, A.J.; Krc, J.; Kinkel, A.W.; Samyn, J.C. Effect of polymorphism on absorption of chloramphenicol from chloramphenicol palmitate. J. Pharm. Sci. 1967, 56, 847-853.
29. Grant, D.; Higuchi, T. Solubility Behaviour of Organic Compounds, 1st ed.; John Wiley & Sons: New York, NY, USA, 1990.
30. Hancock, B.C.; Parks, M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 2000, 17, 397-404.
31. Chawla, G.; Bansal, A.K. A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. Eur. J. Pharm. Sci. 2007, 32, 45-57.
32. Savolainen, M.; Kogermann, K.; Heinz, A.; Aaltonen, J.; Peltonen, L.; Strachan, C.; Yliruusi, J. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Eur. J. Pharm. Biopharm. 2009, 71, 71-79.
33. Zhou, D.; Zhang, G.G.Z.; Law, D.; Grant, D.J.W.; Schmitt, E.A. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. J. Pharm. Sci. 2002, 91, 1863-1872.
34. Graeser, K.A.; Patterson, J.E.; Zeitler, J.A.; Gordon, K.C.; Rades, T. Correlating thermodynamic and kinetic parameters with amorphous stability. Eur. J. Pharm. Sci. 2009, 37, 492-498.
35. Bhugra, C.; Rambhatla, S.; Bakri, A.; Duddu, S.P.; Miller, D.P.; Pikal, M.J.; Lechuga-Ballesteros, D. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility. J. Pharm. Sci. 2007, 96,1258-1269.
36. Bhugra, C.; Shmeis, R.; Krill, S.L.; Pikal, M.J. Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times. J. Pharm. Sci. 2008, 97, 455-472.
37. Masuda, K.; Tabata, S.; Sakata, Y.; Hayase, T.; Yonemochi, E.; Terada, K. Comparison of molecular mobility in the glassy state between amorphous indomethacin and salicin based on spin-lattice relaxation times. Pharm. Res. 2005, 22, 797-805.
38. Patterson, J.E.; James, M.B.; Forster, A.H.; Lancaster, R.W.; Butler, J.M.; Rades, T. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. J. Pharm. Sci. 2005, 94, 1998-2012.
39. Zhang, F.; Aaltonen, J.; Tian, F.; Saville, D.J.; Rades, T. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin. Eur. J. Pharm. Biopharm. 2009, 71, 64-70.
40. Hill, V.L.; Craig, D.Q.M.; Feely, L.C. The effects of experimental parameters and calibration on MTDSC data. Int. J. Pharm. 1999, 192, 21-32.
41. Putnam, R.L.; Boeriogoates, J. Heat-capacity measurements and thermodynamic functions of crystalline sucrose at temperatures from 5 K to 342 K. J. Chem. Thermodyn. 1993, 25, 607-613.
42. Scherer, G.W. Use of the Adam-Gibbs equation in the analysis of structural relaxation. J. Am. Ceram. Soc. 1984, 67, 504-511.
43. Crowley, K.J.; Zografi, G. The use of thermal methods for predicting glass-former fragility. Thermochim. Acta 2001, 380, 79-93.
44. Mao, C.; Prasanth Chamarthy, S.; Byrn, S.R.; Pinal, R. A calorimetric method to estimate molecular mobility of amorphous solids at relatively low temperatures. Pharm. Res. 2006, 23,2269-2276.